Its potential application in managing gut inflammation has garnered significant attention due to its promising results in preclinical studies
Beyond my expectations
Disclosure of interest: Financial support for this study was provided by Alnylam Pharmaceuticals and Biogen Poster Session II - INTRACRANIAL HEMORRHAGE 02.00 - INTRACRANIAL HEMORRHAGE - 02.01 - INTRACEREBRAL HAEMORRHAGE P771 - ESOC25-495 PREHOSPITAL DETECTION OF INTRACRANIAL HEMORRHAGE USING A PORTABLE GFAP DEVICE IN PATIENTS WITH ACUTE FOCAL NEUROLOGICAL DEFICITS OR REDUCED CONSCIOUSNESS TRANSPORTED BY EMERGENCY VEHICLES Iris Voka 1 , Love-Preet Kalra 1 , Sabina Zylyftari 1 , Mastura Ganji 1 , Deepak Bos 1 , Klodiana Meci 1 , Stephan Barthelmes 1 , Gregor Lichy 2,3 , Simon Schwarzach 4 , Till Frscher 5 , Dominik Mayer 5 , Jens Pluto 5 , Timo Breining 5 , Sebastian Luger 1,6 , Christian Foerch 1,6 1 Department of Neurology, RKH Klinikum, Ludwigsburg, Germany, 2 Department of Anesthesiology, Intensive Care Medicine and Pain Medicine, RKH Klinikum, Ludwigsburg, Germany, 3 DRF Luftrettung Stuttgart, Stuttgart, Germany, 4 DRF Luftrettung Karlsruhe, Karlsruhe, Germany, 5 DRK Rettungsdienst Ludwigsburg, Ludwigsburg, Germany, 6 Department of Neurology, University Hospital Frankfurt, Goethe-University, Frankfurt am Main, Germany Background and Aims: Intracerebral hemorrhage(ICH) requires rapid diagnosis for optimal patient outcomes
Importantly, short-term treatment with rifampicin (4 h) did not reduce intracellular bacterial viability (Extended Data Fig
"How Do I Know It's Safe?" When administered in-office by licensed medical professionals following established protocols, BPC-157 is generally very well-tolerated
